INS and Insulin resistance: As a result, this persistent inflammatory condition leads to an impairment of insulin signalling, as well as exacerbating beta (β)-cell dysfunction and obesity-triggered insulin resistance [5,53], along with abnormal tissue remodelling and fibrosis.